Global sensitivity, feasibility, and flexibility analysis of continuous pharmaceutical manufacturing processes

Abstract Simulation models for continuous pharmaceutical manufacturing processes have been developed and adapted as a powerful computer-aided tool to facilitate the process development. Accordingly, process analysis methods have also been implemented to obtain a more extensive process knowledge. In this book chapter, we gave an overview of the recent advances on two aspects of process analysis methods based on simulations: (1) global sensitivity analysis, and (2) feasibility and flexibility analysis methods. Global sensitivity analysis extracts the process knowledge in a “forward” manner: within certain ranges of the inputs, how these inputs can contribute to the variability in the output. On the other hand, feasibility and flexibility analysis evaluates the process in a “backward” manner: given specified ranges (i.e., process constraints) on the output, what is the design space of the inputs within which a process can always remain feasible. These two process analysis strategies together can strengthen the process understanding in developing a pharmaceutical process.

[1]  Jean-Loup Farges,et al.  Improvement of the Representativity of the Morris Method for Air-Launch-to-Orbit Separation , 2014 .

[2]  Andrea Saltelli,et al.  From screening to quantitative sensitivity analysis. A unified approach , 2011, Comput. Phys. Commun..

[3]  Marianthi G. Ierapetritou,et al.  Dynamic Data-Driven Modeling of Pharmaceutical Processes , 2011 .

[4]  M. Ierapetritou,et al.  A novel feasibility analysis method for black‐box processes using a radial basis function adaptive sampling approach , 2017 .

[5]  Marianthi G. Ierapetritou,et al.  An integrated approach for dynamic flowsheet modeling and sensitivity analysis of a continuous tablet manufacturing process , 2012, Comput. Chem. Eng..

[6]  Donald R. Jones,et al.  Efficient Global Optimization of Expensive Black-Box Functions , 1998, J. Glob. Optim..

[7]  B. Iooss,et al.  A Review on Global Sensitivity Analysis Methods , 2014, 1404.2405.

[8]  Lawrence X. Yu,et al.  Advancing pharmaceutical quality: An overview of science and research in the U.S. FDA's Office of Pharmaceutical Quality. , 2016, International journal of pharmaceutics.

[9]  Pedro Hernandez-Abad,et al.  Quality by design case study: an integrated multivariate approach to drug product and process development. , 2009, International journal of pharmaceutics.

[10]  Zilong Wang,et al.  Process analysis and optimization of continuous pharmaceutical manufacturing using flowsheet models , 2017, Comput. Chem. Eng..

[11]  Marianthi G. Ierapetritou,et al.  Computational Approaches for Studying the Granular Dynamics of Continuous Blending Processes, 2 – Population Balance and Data‐Based Methods , 2012 .

[12]  C. Fortuin,et al.  Study of the sensitivity of coupled reaction systems to uncertainties in rate coefficients. I Theory , 1973 .

[13]  I. Sobol.  Uniformly distributed sequences with an additional uniform property , 1976 .

[14]  Mattias Björkman,et al.  Global Optimization of Costly Nonconvex Functions Using Radial Basis Functions , 2000 .

[15]  R. Webster,et al.  Basic Steps in Geostatistics: The Variogram and Kriging , 2015, SpringerBriefs in Agriculture.

[16]  G. K. Raju,et al.  Understanding Pharmaceutical Quality by Design , 2014, The AAPS Journal.

[17]  Fernando J. Muzzio,et al.  Characterizing continuous powder mixing using residence time distribution , 2011 .

[18]  Francis J. Doyle,et al.  Solution technique for a multi-dimensional population balance model describing granulation processes , 2005 .

[19]  Ignacio E. Grossmann,et al.  Operability, Resiliency, and Flexibility: process design objectives for a changing world , 1983 .

[20]  Andrew Prpich,et al.  Drug product modeling predictions for scale-up of tablet film coating - A quality by design approach , 2010, Comput. Chem. Eng..

[21]  Vincentius Surya Kurnia Adi,et al.  A mathematical programming formulation for temporal flexibility analysis , 2013, Comput. Chem. Eng..

[22]  Paola Annoni,et al.  Variance based sensitivity analysis of model output. Design and estimator for the total sensitivity index , 2010, Comput. Phys. Commun..

[23]  Bruno C. Hancock,et al.  Process modeling in the pharmaceutical industry using the discrete element method. , 2009, Journal of pharmaceutical sciences.

[24]  Marianthi G. Ierapetritou,et al.  Surrogate-Based Optimization of Expensive Flowsheet Modeling for Continuous Pharmaceutical Manufacturing , 2013, Journal of Pharmaceutical Innovation.

[25]  Marianthi G. Ierapetritou,et al.  Feasibility and flexibility analysis of black-box processes Part 1: Surrogate-based feasibility analysis , 2015 .

[26]  M. D. McKay,et al.  A comparison of three methods for selecting values of input variables in the analysis of output from a computer code , 2000 .

[27]  Jose E. Tabora,et al.  Modeling-Based Approach Towards Quality by Design for the Ibipinabant API Step , 2012 .

[28]  Lawrence X. Yu,et al.  Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production , 2015, Journal of Pharmaceutical Innovation.

[29]  Julien Jacques,et al.  Sensitivity analysis in presence of model uncertainty and correlated inputs , 2006, Reliab. Eng. Syst. Saf..

[30]  Gintaras V. Reklaitis,et al.  Understanding critical material properties for solid dosage form design , 2006, Journal of Pharmaceutical Innovation.

[31]  Bernhardt L Trout,et al.  Achieving Continuous Manufacturing May 20-21 2014 Continuous Manufacturing Symposium. , 2015, Journal of pharmaceutical sciences.

[32]  Dana Barrasso,et al.  Population Balance Model Validation and Predictionof CQAs for Continuous Milling Processes: toward QbDin Pharmaceutical Drug Product Manufacturing , 2013, Journal of Pharmaceutical Innovation.

[33]  Marianthi G. Ierapetritou,et al.  An Integrated Approach to Simulation of Pharmaceutical Processes for Solid Drug Manufacture , 2014 .

[34]  Chi Wai Hui,et al.  Process Flexibility for Multivariable Systems , 2008 .

[35]  Andy J. Keane,et al.  Engineering Design via Surrogate Modelling - A Practical Guide , 2008 .

[36]  Ignacio E. Grossmann,et al.  Evolution of concepts and models for quantifying resiliency and flexibility of chemical processes , 2014, Comput. Chem. Eng..

[37]  Alison S. Tomlin,et al.  GUI-HDMR - A software tool for global sensitivity analysis of complex models , 2009, Environ. Model. Softw..

[38]  Marianthi G. Ierapetritou,et al.  Derivative‐free optimization for expensive constrained problems using a novel expected improvement objective function , 2014 .

[39]  William Engisch,et al.  Using Residence Time Distributions (RTDs) to Address the Traceability of Raw Materials in Continuous Pharmaceutical Manufacturing , 2015, Journal of Pharmaceutical Innovation.

[40]  Heewon Lee.  Pharmaceutical industry practices on genotoxic impurities , 2014 .

[41]  G. Gary Wang,et al.  Survey of modeling and optimization strategies to solve high-dimensional design problems with computationally-expensive black-box functions , 2010 .

[42]  Saltelli Andrea,et al.  Global Sensitivity Analysis: The Primer , 2008 .

[43]  D. Kirschner,et al.  A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.

[44]  H. Rabitz,et al.  High Dimensional Model Representations , 2001 .